K2M Showcases Growing Portfolio At North American Spine Society 2012 Meeting

In short

Spinal device company K2M, Inc., is supporting its claim to possess a market leading comprehensive product portfolio as it exhibits at the North American Spine Society (NASS) Annual Meeting this week.

Background

K2M claims to be the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures. It certainly looks like the most prolific, having trumpeted numerous new technologies on our own site in recent months. Indeed at last year’s event,  K2M introduced nine new products and promised additional developments including a line of biologic products as well as the introduction of a breakthrough technology to address the most challenging complex deformities.

This year, technologies showcased at the meeting will build upon K2M’s proven track record as a leader in the complex and minimally invasive approaches to the spine, as well as deliver on the company’s commitment to offering solutions for the full spectrum of spinal pathologies. Highlights from K2M to be showcased at NASS for the first time will include:

  • K2M’s breakthrough Rail 4D™ Technology to address the most complex spinal curves. Inspired by structural I-beam geometry, the Rail provides enhanced structural rigidity with particular strength characteristics for maintenance of saggital balance. The Rail 4D system is lower-profile than traditional set screw based technologies.
  • MESA® Small Stature Spinal System, a Ø4.5 mm line extension of the company’s revolutionary low profile, zero torque family of products marking K2M’s first pedicle screw available for small stature patients. With a new enhanced dual lead thread and ergonomic instrumentation, it is poised to address the most difficult correction maneuvers.
  • VESUVIUS™ Osteobiologic Systems and new additions to the VIKOS® Allograft Systems, through a partnership with LifeNet Health®. The VESUVIUS family of products is designed specifically to enhance bone regeneration after spine surgery. The VESUVIUS Fiber product offering is a unique biologic designed to provide optimized porosity, surface area, and structure, translating to optimal osteoinductive potential by maximizing exposure of growth factors. Additionally, the portfolio offers a variety of configurations and sizes to meet surgeons’ clinical needs, while K2M’s VIKOS Cervical now includes unicortical, tricortical, and iliac crest grafts, as well as VIKOS Void Fillers and VIKOS Shafts.
  • SANTORINI™ Corpectomy Cage Systems, manufactured from biocompatible PEEK polymer to allow for an unobstructed view of the post-operative fusion. SANTORINI Solid offers an enlarged graft space, while SANTORINI Expandable allows for in-situ expansion with a locking clip to secure the desired height.

Company comments

“As the fastest growing and largest privately held company in spine, it is critical that K2M continues to invest in research and development with the ongoing vision to constantly provide more efficient and higher-quality products and services,” stated Eric Major, K2M’s President and CEO. “Through strong financial investments and continued innovation K2M continues to expand our global footprint by offering next generation technologies to surgeons in all regions of the world.”

K2M will be located at NASS booth #1100.

Source: K2M, Inc.